
Ozempic 101: A doctor explains the data and science behind weight-loss drugs
ParentData with Emily Oster
Exploring GLP1 Agonists and Their Role in Weight Loss and Diabetes Treatment
The chapter delves into the responsibilities of endocrinologists in addressing hormone-related conditions, particularly diabetes and weight issues, by examining GLP1 agonist drugs like Ozempic and Wigovi. It compares the evolution of these medications from diabetes treatment to weight loss aids, emphasizing their mechanisms of action on insulin regulation and sugar metabolism.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.